Favor, Wisdom (NM-AIST, 2022-08)
The initiation of Dolutegravir based antiretroviral therapy has provided a potent treatment option
for persons living with human immunodeficiency Virus (PLHIV). However, clinical research has
shown overwhelming evidence ...